The PRECEDE Foundation is honored to be featured in the Long Island Press for its upcoming Light the Way Gala, taking place on Tuesday, October 28, 2025, at Tribeca 360º in New York City. This inaugural event will bring together leading scientists, philanthropists, patients, and advocates to raise critical funds to accelerate the early detection of pancreatic cancer—one of the most challenging and deadly cancers to diagnose in time.
Uniting for Hope and Early Detection
With a current five-year survival rate of just 13%, pancreatic cancer remains one of the most difficult cancers to treat. The Light the Way Gala will directly support the PRECEDE Consortium’s groundbreaking research focused on advancing early detection tools, improving screening, and expanding patient-focused programs that aim to increase survival rates to 50% within the next decade.
Dr. Diane Simeone, Director of Moores Cancer Center at UC San Diego and Founding Director of the PRECEDE Consortium, shared:
“When someone says they have pancreatic cancer, the room often falls silent. It’s fast-moving, painful, and notoriously difficult to detect early. But thanks to the PRECEDE Consortium, that silence doesn’t have to mean hopelessness.”
A Global Effort to Save Lives
The PRECEDE Consortium represents a global initiative reimagining pancreatic cancer detection and care. With more than 9,000 high-risk individuals enrolled across 60 academic institutions worldwide, PRECEDE is leading international collaboration through centralized data, open science, and shared learning to address a global health crisis head-on.
Honoring Leaders, Survivors, and Advocates
Guests attending the Gala will enjoy an evening program featuring Emmy-winning journalist Kate Bolduan as emcee and Katie Couric as presenter. The night will include a live auction, inspiring patient stories, and recognition of this year’s honorees:
-
Catalyst for Change Award – Ambry Genetics Corporation
-
Nobility in Science Award – Dr. Raymond C. Wadlow
-
Legacy Awards – Jeffrey Johnson, Esq. & Jonathan Morris, Esq.
-
PRECEDE Leadership and Compassionate Care Award – Jessica Everett
-
Voice of Hope Award – Ivy Duneier
PRECEDE Foundation Board President Jamie Brickell, a pancreatic cancer survivor, reflected:
“When I was diagnosed in 2020, early detection saved my life. Too often, patients don’t get that chance. PRECEDE is working to make early detection the norm rather than the exception. This Gala is about giving families hope and supporting the science that can transform outcomes.”
Powered by Generosity and Collaboration
The Light the Way Gala is made possible thanks to the generosity of sponsors including Ambry Genetics (Presenting Sponsor), Inova (Friend Sponsor), and Eversheds Sutherland and Troutman Pepper Locke (Community Sponsors), among many others. Their support helps sustain PRECEDE’s mission to improve early detection and survival for patients worldwide.